Mount Sinai Innovation Partners

Mount Sinai Innovation Partners drives the real-world application and commercialization of Mount Sinai discoveries and inventions, and develops research partnerships with industry. It translates discoveries into health care products and services that benefit patients and society, and oversees the full spectrum of commercialization activities needed to bring Mount Sinai inventions to life, including evaluating, patenting, marketing and licensing new technologies, and forming collaborations with commercial and nonprofit entities. It supports material transfer, confidentiality and coaching of innovators to advance translational discoveries, while fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system. Based in New York and established in 2012, it serves as an innovation accelerator focused on healthcare, digital health and life sciences.

Dov Shamir Ph.D

Head of Elementa Labs

14 past transactions

NousQ Pte

Funding Round in 2024
NousQ Pte Ltd is a Singapore-based start-up that focuses on the design, development, manufacturing, and commercialization of medical technology and devices aimed at improving patient care. Since its pivot in July 2021, the company has concentrated on creating innovative solutions for specific medical challenges, particularly in the treatment of glue ear. Its flagship product utilizes a uniquely programmed sensor and automated algorithm that adapts to various eardrum conditions, offering a novel approach to managing this common ailment. By enhancing the treatment process, NousQ aims to reduce costs, minimize surgical risks, and lessen complications associated with glue ear, thereby delivering effective patient-centric medical resolutions.

AvoMD

Seed Round in 2023
AvoMD is a no-code software platform that converts clinical content into 'virtual clinical consults', providing instant expert guidance at the bedside. It improves healthcare outcomes while saving clinicians approximately half of their time spent on accessing and using information.

Memoria

Funding Round in 2023
Memoria provides an online platform for memorial services. They also sell pine caskets, steel caskets, wood cremation urns, photo frame cremation urns, photo prayer cards for funerals, remembrance and sympathy gifts, memorial photo pillar candles, funeral flowers, and cremation jewelry.

Jelikalite

Funding Round in 2023
Jelikalite develops medical equipment for children with autism spectrum disorders, focusing on non-invasive approaches to support brain health. The company has created a therapeutic wearable device that combines near-infrared light, sensors, and a machine-learning personalization system to deliver non-invasive brain stimulation. Designed for home-based use without a therapist's physical presence, the device seeks to improve communication, responsiveness, and social interaction in children with autism.

EmpiricaLab

Funding Round in 2023
EmpiricaLab develops an online learning platform tailored for healthcare teams. It facilitates peer learning through collaborative authoring, sharing of work-relevant content, and a work-integrated learning curriculum.

A.D.A.M.

Funding Round in 2022
A.D.A.M. is a 3D bioprinting startup focused on developing a Point-of-Care Medical Device Production System specifically for bone implants. The company aims to revolutionize the medical field by providing hospitals with the capability to produce personalized, bio-resorbable, and biodegradable implants in-house, significantly reducing costs and time associated with traditional manufacturing processes. A.D.A.M.'s turnkey system, which can be installed and operational within three months, combines proprietary printing technology, materials, and software to streamline the production of custom implants. This innovative approach contrasts sharply with the existing market, where hospitals face high setup costs and lengthy timelines for establishing their own 3D printing capabilities. By offering a subscription-based service model, A.D.A.M. not only lowers operational expenses but also facilitates scalability across different healthcare settings. The company has established partnerships with notable institutions, enhancing its market strategy and positioning as a leader in on-demand personalized tissue manufacturing.

Vivo Surgical

Funding Round in 2022
Vivo Surgical is a medical device company focused on addressing global healthcare needs through innovative applications of science and technology. It specializes in developing devices such as an endoscopic diagnostic device and a surgical lighting device, aimed at enhancing medical practices in hospitals. Vivo Surgical emphasizes a need-based assessment of health systems, collaborating with local clinical stakeholders throughout the product development process to ensure that its technologies are fit for purpose. This approach enables medical professionals to effectively tackle the challenges presented by current trends in the medical technology industry.

HelpWear

Seed Round in 2022
HelpWear develops a waterproof wearable device that monitors heart activity, detects heart attacks, and sends real-time alerts to medical facilities. Incorporated in 2015, the company is based in Toronto, Canada.

Empo Health

Funding Round in 2022
Empo Health is a company focused on in-home health monitoring, specifically designed to enhance patient care and outcomes. It has developed an innovative bathroom scale and digital health platform that allows for the early detection of diabetic foot conditions, thereby helping to prevent amputations. The products offered by Empo Health include bathroom scales and full-color imaging scales that provide reliable visual data to both patients and clinicians, facilitating better monitoring outside the clinical setting. This integration into patients' daily lives aims to improve the standard of care for individuals at risk of diabetes-related complications.

CurioInvest

Seed Round in 2021
CurioInvest is a financial technology company specializing in the tokenization of real-world assets, with a primary focus on collectible and rare exclusive cars. By leveraging blockchain technology, CurioInvest aims to make investments in this lucrative market accessible to a broader audience, eliminating high capital requirements and costly intermediaries. The company recognizes that collectible cars have significantly outperformed traditional investment indices since 2008 and seeks to pioneer the adoption of distributed ledger technologies within the automotive sector. Through its innovative platform, CurioInvest enables investors to directly participate in the market for high-value collectibles, simplifying the investment process and fostering a new era of asset ownership.

Aeragen

Pre Seed Round in 2021
Aeragen is a medical technology company focused on preventing the spread of airborne infectious diseases in healthcare settings. It develops innovative devices aimed at improving patient care and addressing persistent issues in hospitals, clinics, and emergency medical services.

AvoMD

Seed Round in 2021
AvoMD is a no-code software platform that converts clinical content into 'virtual clinical consults', providing instant expert guidance at the bedside. It improves healthcare outcomes while saving clinicians approximately half of their time spent on accessing and using information.

Retina Technologies

Grant in 2019
Retina Technologies is a developer of innovative vision screening technology that aims to enhance accessibility and affordability in eye care. The company has introduced OcuVue, a modular digital vision medical device and platform that revolutionizes vision screening and early detection of eye conditions. By leveraging virtual reality and machine learning, Retina Technologies facilitates comprehensive vision screening in resource-limited medical settings, allowing eye specialists to examine and treat a larger number of patients efficiently. Their end-to-end solution connects primary care providers, vision care providers, and vision specialists, promoting collaboration in the prevention of blindness and improving overall eye health outcomes.

Rx.Health

Seed Round in 2018
Rx.Health, Inc. is a digital health company founded in 2016 and headquartered in Secaucus, New Jersey. It specializes in creating a comprehensive digital medicine platform that allows healthcare providers to prescribe evidence-based mobile health applications, multimedia education, and digital therapeutics directly to patients at the point of care. As a spinoff from the Mount Sinai Health System, Rx.Health has developed the RxUniverse platform, which enables providers to efficiently prescribe and monitor digital therapeutics and patient care plans. The platform supports various clinical specialties and aims to enhance patient outcomes while reducing readmission penalties for health systems. Additionally, Rx.Health offers tools such as electronic patient-reported outcomes surveys, telehealth messaging, data analytics, and integration with wearable devices and genomics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.